Abstract
Background
Adenoma detection rate (ADR) and sessile serrated polyp detection rate (SSPDR) data in surveillance colonoscopy are limited.
Aims
Our aim was to determine surveillance ADR and SSPDR and identify associated predictors.
Methods
A retrospective review of subjects who underwent surveillance colonoscopy for adenoma and/or SSP at an academic center was performed. The following exclusion criteria were applied: prior colonoscopy ≤ 3 years, incomplete examination, or another indication for colonoscopy. Patient, endoscopist, and procedure characteristics were collected. Predictors were identified using multivariable logistic regression.
Results
Of 3807 colonoscopies, 2416 met inclusion criteria. Surveillance ADR was 49% and, SSPDR was 8%. Higher ADR was associated with: age per year (OR 1.03; 95% CI 1.02–1.04), male gender (OR 1.55; 95% CI 1.29–1.88), BMI per kg/m2 (OR 1.02; 95% CI 1.01–1.04), withdrawal time per minute (OR 1.09; 95% CI 1.07–1.10), and endoscopists’ screening ADR (OR 1.01; 95% CI 1.00–1.03). Years since training (OR 0.99; 95% CI 0.98–0.99) was associated with lower ADR. Family history of CRC (OR 1.58; 95% CI 1.02–2.27) and endoscopists’ screening ADR (OR 1.40; 95% CI 1.15–1.74) were associated with higher SSPDR. African-American race (OR 0.36; 95% CI 0.10–0.75) and diabetes (OR 0.41; 95% CI 0.21–0.76) were associated with lower SSPDR.
Conclusions
For surveillance colonoscopy, nearly half of patients had an adenoma and one in twelve had an SSP. In addition to established factors, BMI, endoscopists’ screening ADR, and years since training were associated with ADR, whereas African-American race and diabetes were inversely associated with SSPDR. Further studies are needed prior to integrating surveillance ADR and SSPDR into quality metrics.
Similar content being viewed by others
Abbreviations
- ADR:
-
Adenoma detection rate
- BMI:
-
Body mass index
- CI:
-
Confidence interval
- CRC:
-
Colorectal cancer
- FH:
-
Family history
- OR:
-
Odds ratio
- SD:
-
Standard deviation
- SSP:
-
Sessile serrated polyp
- SSPDR:
-
Sessile serrated polyp detection rate
- US:
-
United States
References
American Cancer Society: Cancer Facts & Figures 2016 [Internet]. American Cancer Society 2016 [cited 2016]; Available from: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf.
Rex DK, Schoenfeld PS, Cohen J, et al. Quality indicators for colonoscopy. Gastrointest Endosc. 2015;81:31–53.
Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006;14:2533–2541.
Chen SC, Rex DK. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am J Gastroenterol. 2007;102:856–861.
Shaukat A, Oancea C, Bond JH, Church TR, Allen JI. Variation in detection of adenomas and polyps by colonoscopy and change over time with a performance improvement program. Clin Gastroenterol Hepatol. 2009;7:1335–1340.
Imperiale TF, Glowinski EA, Juliar BE, Azzouz F, Ransohoff DF. Variation in polyp detection rates at screening colonoscopy. Gastrointest Endosc. 2009;69:1288–1295.
Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010;13:1795–1803.
Anderson JC, Butterly LF, Goodrich M, Robinson CM, Weiss JE. Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the new hampshire colonoscopy registry. Clin Gastroenterol Hepatol. 2013;11:1308–1312.
Kahi CJ, Hewett DG, Norton DL, Eckert GJ, Rex DK. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol. 2011;1:42–46.
Anderson JC, Butterly LF, Weiss JE, Robinson CM. Providing data for serrated polyp detection rate benchmarks: an analysis of the New Hampshire Colonoscopy Registry. Gastrointest Endosc. 2017;1:1188–1194.
Lieberman DA, Williams JL, Holub JL, et al. Colonoscopy utilization and outcomes 2000 to 2011. Gastrointest Endosc. 2014;80:133–143.
Pinsky PF, Schoen RE, Weissfeld JL, et al. The yield of surveillance colonoscopy by adenoma history and time to examination. Clin Gastroenterol Hepatol. 2009;1:86–92.
Sanaka MR, Rai T, Navaneethan U, et al. Adenoma detection rate in high-risk patients differs from that in average-risk patients. Gastrointest Endosc. 2016;83:172–178.
Corley DA, Jensen CD, Marks AR, et al. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013;11:172–180.
Anderson JC, Butterly LF, Goodrich M, Robinson CM, Weiss JE. Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the new hampshire colonoscopy registry. Clin Gastroenterol Hepatol. 2013;11:1308–1312.
Lieberman D, Mascarenhas R. Adenoma detection rate: in search of quality improvement, not just measurement. Gastrointest Endosc. 2015;82:683–685.
Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;19:169–174.
Rex DK, Lehman GA, Ulbright TM, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol. 1993;88:825–831.
Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med. 2000;19:162–168.
Kanadiya MK, Gohel TD, Sanaka MR, Thota PN, Shubrook JH Jr. Relationship between type-2 diabetes and use of metformin with risk of colorectal adenoma in an American population receiving colonoscopy. J Diabetes Complicat. 2013;10:463–466.
Shaukat A, Rector TS, Church TR, et al. Longer withdrawal time is associated with a reduced incidence of interval cancer after screening colonoscopy. Gastroenterology. 2015;149:952–957.
Butterly L, Robinson CM, Anderson JC, et al. Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol. 2014;7:417–426.
Buchner AM, Shahid MW, Heckman MG, et al. Trainee participation is associated with increased small adenoma detection. Gastrointest Endosc. 2011;1:1223–1231.
Rogart JN, Siddiqui UD, Jamidar PA, Aslanian HR. Fellow involvement may increase adenoma detection rates during colonoscopy. Am J Gastroenterol. 2008;103:2841–2846.
Peters SL, Hasan AG, Jacobson NB, Austin GL. Level of fellowship training increases adenoma detection rates. Clin Gastroenterol Hepatol. 2010;1:439–442.
Anderson JC, Rangasamy P, Rustagi T, et al. Risk factors for sessile serrated adenomas. J Clin Gastroenterol. 2011;1:694–699.
Haque TR, Bradshaw P, Crockett SD. HHS public access. Dig Dis Sci. 2014;26:2874–2889.
Buchner AM, Shahid MW, Heckman MG, et al. Trainee participation is associated with increased small adenoma detection. Gastrointest Endosc. 2011;1:1223–1231.
Author information
Authors and Affiliations
Contributions
Stacy Menees, Joseph Dickens, and Jennifer Maratt had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. SM was involved in study concept and design. SM, JD, JM, DR, CE, and KJ were involved in acquisition, analysis, or interpretation of data. JM, JD, and SM were involved in drafting of the manuscript. All authors were involved in critical revision of the manuscript for important intellectual content. JD, SM, JM, and KJ were involved in statistical analysis. SM was involved in study supervision.
Corresponding author
Ethics declarations
Conflict of interest
Grace Elta has been a consultant for Olympus Medical. Philip Schoenfeld has been a consultant, a member of the advisory board, and on the speaker bureau for Ironwood Pharmaceuticals, Allergan Pharmaceuticals, Salix Pharmaceuticals, and a consultant and member of the advisory board for Synergy Pharmaceuticals. All other authors have no conflicts of interest to report.
Ethical Approval
All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this retrospective study, formal consent was not required. This article does not contain any studies with animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Maratt, J.K., Dickens, J., Schoenfeld, P.S. et al. Factors Associated with Surveillance Adenoma and Sessile Serrated Polyp Detection Rates. Dig Dis Sci 62, 3579–3585 (2017). https://doi.org/10.1007/s10620-017-4792-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-017-4792-7